How science and collaboration led to a breakthrough in transthyretin cardiac amyloidosis | STAT
Science & Technology News
Recognizing the promise of this discovery, in 2010 Pfizer made a scientific commitment to study the tafamidis meglumine molecule, a TTR stabilizer, ...
